Equillium (EQ) Depreciation & Amortization (CF) (2018 - 2026)
Equillium's (EQ) quarterly Depreciation & Amortization (CF) came in at $24000.0 in Q1 2026, down 27.27% year-on-year from $33000.0 in Q1 2025, and up 242.86% on a QoQ basis from $7000.0 in Q4 2025.
Equillium (EQ) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends
Equillium (EQ) has 9 years of Depreciation & Amortization (CF) data on file, last reported at $24000.0 in Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) fell 27.27% year-over-year to $24000.0 in Q1 2026; TTM through Mar 2026 was $91000.0, a 9.9% decrease from a year earlier, with the FY2025 full-year figure at $100000.0, changed 0.0% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $24000.0, up from $7000.0 in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for EQ reached as high as $35000.0 in Q2 2024 and fell as low as -$2000.0 in Q4 2024.
- Historically, Depreciation & Amortization (CF) has averaged $27529.4 across 5 years, with a median of $31000.0 in 2022.
- Across the five-year window, Depreciation & Amortization (CF) slumped 106.06% in 2024 and soared 450.0% in 2025, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $32000.0 in 2022, then grew by 3.12% to $33000.0 in 2023, then slumped by 106.06% to -$2000.0 in 2024, then surged by 450.0% to $7000.0 in 2025, then soared by 242.86% to $24000.0 in 2026.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $24000.0 in Q1 2026, $7000.0 in Q4 2025, and $28000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Equillium | 258.99 Mn | 258.99 Mn | - | 24,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24,000.00 |
| Mar 31, 2026 | 24,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Sep 30, 2025 | 28,000.00 |
| Sep 30, 2025 | 28,000.00 |
| Jun 30, 2025 | 32,000.00 |
| Jun 30, 2025 | 32,000.00 |
| Mar 31, 2025 | 33,000.00 |
| Mar 31, 2025 | 33,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Sep 30, 2024 | 35,000.00 |
| Sep 30, 2024 | 35,000.00 |
| Jun 30, 2024 | 35,000.00 |
| Jun 30, 2024 | 35,000.00 |
| Mar 31, 2024 | 32,000.00 |
| Mar 31, 2024 | 32,000.00 |
| Dec 31, 2023 | 33,000.00 |
| Dec 31, 2023 | 33,000.00 |